Expert articles on AI automation, business process optimization, and practical tips for modernizing your operations.
In a move that separates the front-runner from the pack, Alphabet's self-driving unit Waymo has raised $5.6 billion in new funding. This massive investment, reported by The New York Times, arrives...
Palantir Technologies Inc. posted fourth-quarter results that beat Wall Street's forecasts, sending its stock up 10% after the bell. The company, once known primarily for its government work,...
Shares of Advanced Micro Devices (AMD) moved higher Tuesday as investors grew optimistic ahead of the chipmaker's quarterly earnings report. The positive sentiment stems from a growing belief on...
After years of rumors, Apple's first foldable iPhone is taking concrete shape. According to supply chain reports and analysis, the device is poised to be the company's most significant hardware...
After a prolonged period of pressure, select names in the software sector are drawing fresh analysis for their potential recovery. Investors are closely watching companies like ServiceNow,...
A new artificial intelligence tool designed for corporate legal departments triggered a significant sell-off of European data and publishing stocks on Tuesday. The tool, launched by U.S.-based AI...
Novo Nordisk's U.S.-listed shares dropped sharply Tuesday after the Danish pharmaceutical giant projected a decline in sales and profit for 2026. The stock fell 14% following a trading halt, a...
Pfizer delivered a stronger-than-anticipated fourth quarter, surpassing Wall Street forecasts even as sales of its Covid-19 products continued to soften. The company simultaneously reaffirmed its...
James Park and Eric Friedman, who sold their wearable tech pioneer Fitbit to Google, are re-entering the health technology field. Their new startup, Luffu, is a self-funded project currently in...
In a move that has redefined corporate scale, Elon Musk has merged his artificial intelligence company, xAI, with his rocket firm, SpaceX. The strategic integration, announced in February 2026,...
In a significant development for its metabolic health pipeline, Pfizer announced promising mid-stage trial results for a new monthly obesity injection. The data, released Tuesday alongside...
Pharmaceutical giant Merck & Co. reported stronger-than-expected quarterly profits on Thursday, but its tempered forecast for the full year underscores a significant challenge ahead: the loss of...